Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2YL)-3-(5 -methyl-2-oxo-hexyl)-1-isoindolinone
Details for Australian Patent Application No. 2003212585 (hide)
International Classifications
Event Publications
24 July 2003 Complete Application Filed
Priority application(s): 60/368,609 29.03.02 US
20 November 2003 Application Open to Public Inspection
Published as AU-B-2003212585
21 April 2005 Assignment before Grant
Warner-Lambert Company LLC The application has been assigned to Indevus Pharmaceuticals, Inc.
26 February 2009 Application Accepted
Published as AU-B-2003212585
25 June 2009 Standard Patent Sealed
16 July 2009 Assignment Registered
Indevus Pharmaceuticals, Inc. The patent has been assigned to Endo Pharmaceuticals Solutions Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003212586-RAZOR CARTRIDGE MOUNTING STRUCTURE
2003212584-PROJECTILE COMPRISING A SUBCALIBER PENETRATOR CORE
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser